TCIM
EXAS

TIAA CREF Investment Management’s Exact Sciences EXAS Stock Holding History

TIAA CREF Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$40.2M Buy
463,768
+51,487
+12% +$4.38M 0.03% 458
2018
Q4 		$26M Sell
412,281
-4,943
-1% -$339K 0.02% 561
2018
Q3 		$32.9M Sell
417,224
-2,327
-0.6% -$152K 0.02% 562
2018
Q2 		$25.1M Buy
419,551
+20,947
+5% +$1.13M 0.02% 651
2018
Q1 		$16.1M Buy
398,604
+91,701
+30% +$4.47M 0.01% 856
2017
Q4 		$16.1M Sell
306,903
-23,385
-7% -$1.25M 0.01% 885
2017
Q3 		$15.6M Buy
330,288
+9,601
+3% +$386K 0.01% 883
2017
Q2 		$11.3M Buy
320,687
+10,329
+3% +$319K 0.01% 1058
2017
Q1 		$7.33M Sell
310,358
-19,640
-6% -$389K 0.01% 1336
2016
Q4 		$4.41M Sell
329,998
-8,626
-3% -$139K ﹤0.01% 1682
2016
Q3 		$6.29K Buy
338,624
+20,167
+6% +$355K ﹤0.01% 1444
2016
Q2 		$3.9M Buy
318,457
+1,040
+0.3% +$7.83K ﹤0.01% 1720
2016
Q1 		$2.14M Sell
317,417
-1,131
-0.4% -$7.24K ﹤0.01% 2029
2015
Q4 		$2.94M Sell
318,548
-16,597
-5% -$154K ﹤0.01% 1917
2015
Q3 		$6.03M Buy
335,145
+28,191
+9% +$648K ﹤0.01% 1412
2015
Q2 		$9.13M Buy
306,954
+6,084
+2% +$153K 0.01% 1217
2015
Q1 		$6.63M Buy
300,870
+8,943
+3% +$227K ﹤0.01% 1433
2014
Q4 		$8.01M Sell
291,927
-15,731
-5% -$383K 0.01% 1279
2014
Q3 		$5.96M Sell
307,658
-6,551
-2% -$120K ﹤0.01% 1479
2014
Q2 		$5.35M Buy
314,209
+38,903
+14% +$536K ﹤0.01% 1650
2014
Q1 		$3.9M Sell
275,306
-5,910
-2% -$79.8K ﹤0.01% 1799
2013
Q4 		$3.29M Buy
281,216
+9,000
+3% +$103K ﹤0.01% 1919
2013
Q3 		$3.21M Buy
272,216
+7,595
+3% +$97.5K ﹤0.01% 1908
2013
Q2 		$3.68M Buy
+264,621
New +$2.87M ﹤0.01% 1758

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

TIAA CREF Investment Management's EXAS Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Exact Sciences (EXAS) stake by 12% in Q1 2019, buying an estimated $4.38M and bringing the position to 463,768 shares worth $40.2M. The position accounts for 0.03% of the portfolio, ranked #458.

TIAA CREF Investment Management first reported a position in EXAS in Q2 2013 and has held it in 24 quarters since. 424 funds tracked by Wall St. Rank hold EXAS as of Q1 2019.

  • TIAA CREF Investment Management held 463,768 shares of Exact Sciences worth $40.2M as of Q1 2019.
  • TIAA CREF Investment Management bought 51,487 Exact Sciences shares in Q1 2019, an estimated $4.38M.
  • Exact Sciences made up 0.03% of TIAA CREF Investment Management's portfolio in Q1 2019, its #458 holding.
  • TIAA CREF Investment Management first reported a position in Exact Sciences in Q2 2013 and has held it in 24 quarters since.
  • 424 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.